Patient distribution in 10-year age groups | Download Scientific Diagram
JoF | Free Full-Text | Lipid Species in the GI Tract are Increased by the Commensal Fungus Candida albicans and Decrease the Virulence of Clostridioides difficile | HTML
Prognostic factors for severe and recurrent Clostridioides difficile infection: a systematic review - ScienceDirect
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial - The Lancet Infectious Diseases
A population-based spatio-temporal analysis of Clostridium difficile infection in Queensland, Australia over a 10-year period - Journal of Infection
In vitro susceptibility of Clostridium difficile to cephalosporins... | Download Table
A population-based spatio-temporal analysis of Clostridium difficile infection in Queensland, Australia over a 10-year period - Journal of Infection
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a ran
JoF | Free Full-Text | Lipid Species in the GI Tract are Increased by the Commensal Fungus Candida albicans and Decrease the Virulence of Clostridioides difficile | HTML
Patient disposition. CDAD = C. difficile-associated diarrhea; mITT =... | Download Scientific Diagram
Prognostic factors for severe and recurrent Clostridioides difficile infection: a systematic review - ScienceDirect
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial - The Lancet Infectious Diseases
JoF | Free Full-Text | Lipid Species in the GI Tract are Increased by the Commensal Fungus Candida albicans and Decrease the Virulence of Clostridioides difficile | HTML
JoF | Free Full-Text | Lipid Species in the GI Tract are Increased by the Commensal Fungus Candida albicans and Decrease the Virulence of Clostridioides difficile | HTML
Growth (a) and toxin levels (b and c) for C. difficile strain UK-14 (an... | Download Scientific Diagram
Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells | BMC Microbiology | Full Text
JoF | Free Full-Text | Lipid Species in the GI Tract are Increased by the Commensal Fungus Candida albicans and Decrease the Virulence of Clostridioides difficile | HTML
Growth (a) and toxin levels (b and c) for C. difficile strain ATCC... | Download Scientific Diagram
Microbiota-based markers predictive of development of Clostridioides difficile infection | Nature Communications
A population-based spatio-temporal analysis of Clostridium difficile infection in Queensland, Australia over a 10-year period
Proton Pump Inhibitors and C. Difficile: A Review of The Clinical Evidence
Novel risk factors for recurrent Clostridium difficile infection in children. - Abstract - Europe PMC
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults - Clinical Microbiology and Infection
Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics | Nature Communications
The epidemiology of Clostridium difficile infection in Australia
Microbiota-based markers predictive of development of Clostridioides difficile infection | Nature Communications
